Enhancing Peripheral Vascular Disease Outcomes
Leveraging evidence and expertise to improve the safety and cost of PVD care.
Musculoskeletal Patient Success Story
60-year-old Don*, who was in a motor vehicle accident a little over a year ago, is still suffering from persistent back pain. Learn how EviCore helped both Don and his provider empower the improvement of care through utilization management.
Evidence-Based Care for Peripheral Vascular Intervention
Unnecessary, potentially dangerous peripheral vascular interventions highlight the need for evidence-based care.
Improving Radiology Site of Care Management
Creating better outcomes and experiences with a personalized concierge approach.
All Insights
There may not be a more misunderstood part of the health care system than utilization management (UM). UM helps ensure that members receive health care services that are appropriate, necessary, and cost-effective.
Leveraging evidence and expertise to improve the safety and cost of PVD care.
60-year-old Don*, who was in a motor vehicle accident a little over a year ago, is still suffering from persistent back pain. Learn how EviCore helped both Don and his provider leverage clinical expertise through EviCore's utilization management.
Unnecessary, potentially dangerous peripheral vascular interventions highlight the need for evidence-based care.
Creating better outcomes and experiences with a personalized concierge approach.
From savings to plan performance, uncover the power of Radiology Site of Care management.
The Centers for Medicare & Medicaid Services (CMS) recently released its Advancing Interoperability and Improving Prior Authorization Processes final rule. We sat down with Chief Medical Officer Eric Gratias, M.D., to talk about how well prepared EviCore by Evernorth® is for the rule and what it means for patients, providers and payers.
Did you know laboratory tests influence two-thirds of clinical decisions? While the right tests enable better diagnoses and treatment, the wrong ones can often do more harm than good.
The fact that 25%–40% of musculoskeletal (MSK) care spending is wasteful or ineffective is concerning enough. But coupled with the knowledge that more than 50% of U.S. adults over 18 live with an MSK condition, the potential impact of low-value MSK care is staggering.